INS and hepatocellular carcinoma: According to prospective follow-up studies conducted in Taiwan, insulin use together with smoking may significantly increase the risk of mortality from hepatocellular carcinoma, bladder cancer, and pancreatic cancer in patients with T2D, among others34–36.